1. Home
  2. CDT vs UK Comparison

CDT vs UK Comparison

Compare CDT & UK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • UK
  • Stock Information
  • Founded
  • CDT 2019
  • UK 2015
  • Country
  • CDT United States
  • UK China
  • Employees
  • CDT N/A
  • UK N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • UK Business Services
  • Sector
  • CDT Health Care
  • UK Consumer Discretionary
  • Exchange
  • CDT Nasdaq
  • UK Nasdaq
  • Market Cap
  • CDT 2.2M
  • UK 2.3M
  • IPO Year
  • CDT N/A
  • UK N/A
  • Fundamental
  • Price
  • CDT $2.70
  • UK $1.05
  • Analyst Decision
  • CDT
  • UK
  • Analyst Count
  • CDT 0
  • UK 0
  • Target Price
  • CDT N/A
  • UK N/A
  • AVG Volume (30 Days)
  • CDT 618.7K
  • UK 24.1K
  • Earning Date
  • CDT 08-11-2025
  • UK 07-07-2025
  • Dividend Yield
  • CDT N/A
  • UK N/A
  • EPS Growth
  • CDT N/A
  • UK N/A
  • EPS
  • CDT N/A
  • UK N/A
  • Revenue
  • CDT N/A
  • UK $23,924,045.00
  • Revenue This Year
  • CDT N/A
  • UK N/A
  • Revenue Next Year
  • CDT N/A
  • UK N/A
  • P/E Ratio
  • CDT N/A
  • UK N/A
  • Revenue Growth
  • CDT N/A
  • UK N/A
  • 52 Week Low
  • CDT $2.21
  • UK $0.98
  • 52 Week High
  • CDT $1,515.00
  • UK $2.26
  • Technical
  • Relative Strength Index (RSI)
  • CDT 37.18
  • UK 46.05
  • Support Level
  • CDT $2.57
  • UK $0.98
  • Resistance Level
  • CDT $2.85
  • UK $1.12
  • Average True Range (ATR)
  • CDT 0.24
  • UK 0.05
  • MACD
  • CDT 0.25
  • UK 0.00
  • Stochastic Oscillator
  • CDT 58.05
  • UK 49.93

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, Marketing and branding services, and Other services. Marketing and branding services generate the majority of the company's revenue.

Share on Social Networks: